Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Parkinson's Disease

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 41 articles: HTML format

Single Articles

May 2025
1. 
   Correction for Masliah et al., beta-Amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
   Proc Natl Acad Sci U S A. 2025;122:e2509530122.
   PubMed    
   
   
   April 2025
2. SONDERMANN P, Diercks CS, Rong C, Schultz PG, et al
   Targeted degradation of alpha-Synuclein using an evolved botulinum toxin protease.
   Proc Natl Acad Sci U S A. 2025;122:e2426745122.
   PubMed     Abstract available
   
   
   February 2025
3. BAGNOLI E, Lin YE, Burel S, Jaimon E, et al
   Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain.
   Proc Natl Acad Sci U S A. 2025;122:e2412029122.
   PubMed     Abstract available
   
   
   November 2024
4. GILBOA T, Ter-Ovanesyan D, Wang SC, Whiteman S, et al
   Measurement of alpha-synuclein as protein cargo in plasma extracellular vesicles.
   Proc Natl Acad Sci U S A. 2024;121:e2408949121.
   PubMed     Abstract available
   
   
   October 2024
5. WILLIAMS D, Glasstetter LM, Jong TT, Chen T, et al
   High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson's disease.
   Proc Natl Acad Sci U S A. 2024;121:e2406009121.
   PubMed     Abstract available
   
   
   
6. COLEMAN CR, Pallos J, Arreola-Bustos A, Wang L, et al
   Natural variation in age-related dopamine neuron degeneration is glutathione dependent and linked to life span.
   Proc Natl Acad Sci U S A. 2024;121:e2403450121.
   PubMed     Abstract available
   
   
   September 2024
7. WANG X, Geng J, Rimal S, Sui Y, et al
   The p53 target DRAM1 modulates calcium homeostasis and ER stress by promoting contact between lysosomes and the ER through STIM1.
   Proc Natl Acad Sci U S A. 2024;121:e2400531121.
   PubMed     Abstract available
   
   
   
8. 
   Correction to Supporting Information for Woerman et al., Familial Parkinson's point mutation abolishes multiple system atrophy prion replication.
   Proc Natl Acad Sci U S A. 2024;121:e2417229121.
   PubMed    
   
   
   
9. URIBE-CANO S, Kottmann AH
   The primary cilium of cholinergic neurons may be a linchpin in the progression of Parkinson's Disease.
   Proc Natl Acad Sci U S A. 2024;121:e2414226121.
   PubMed    
   
   
   
10. KIM Y, McInnes J, Kim J, Liang YHW, et al
    Olfactory deficit and gastrointestinal dysfunction precede motor abnormalities in alpha-Synuclein G51D knock-in mice.
    Proc Natl Acad Sci U S A. 2024;121:e2406479121.
    PubMed     Abstract available
    
    
    
11. 
    Correction to Supporting Information for Chen et al., Parkinson's disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration.
    Proc Natl Acad Sci U S A. 2024;121:e2416001121.
    PubMed    
    
    
    August 2024
12. LIU K, Tao Y, Zhao Q, Xia W, et al
    Binding adaptability of chemical ligands to polymorphic alpha-synuclein amyloid fibrils.
    Proc Natl Acad Sci U S A. 2024;121:e2321633121.
    PubMed     Abstract available
    
    
    
13. DEWISON KM, Rowlinson B, Machin JM, Crossley JA, et al
    Residues 2 to 7 of alpha-synuclein regulate amyloid formation via lipid-dependent and lipid-independent pathways.
    Proc Natl Acad Sci U S A. 2024;121:e2315006121.
    PubMed     Abstract available
    
    
    
14. ROSENKRANTZ JL, Brandorff JE, Raghib S, Kapadia A, et al
    ZNF91 is an endogenous repressor of the molecular phenotype associated with X-linked dystonia-parkinsonism (XDP).
    Proc Natl Acad Sci U S A. 2024;121:e2401217121.
    PubMed     Abstract available
    
    
    
15. KHAN SS, Jaimon E, Lin YE, Nikoloff J, et al
    Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson's disease.
    Proc Natl Acad Sci U S A. 2024;121:e2402206121.
    PubMed     Abstract available
    
    
    
16. CONNELLY EM, Rintala-Dempsey AC, Gundogdu M, Freeman EA, et al
    Capturing the catalytic intermediates of parkin ubiquitination.
    Proc Natl Acad Sci U S A. 2024;121:e2403114121.
    PubMed     Abstract available
    
    
    July 2024
17. HOY CW, de Hemptinne C, Wang SS, Harmer CJ, et al
    Beta and theta oscillations track effort and previous reward in the human basal ganglia and prefrontal cortex during decision making.
    Proc Natl Acad Sci U S A. 2024;121:e2322869121.
    PubMed     Abstract available
    
    
    
18. GUPTA S, Tielemans A, Guevara CA, Huntley GW, et al
    Parkinson's-linked LRRK2-G2019S derails AMPAR trafficking, mobility, and composition in striatum with cell-type and subunit specificity.
    Proc Natl Acad Sci U S A. 2024;121:e2317833121.
    PubMed     Abstract available
    
    
    
19. 
    Correction for Ahuja et al., Bach1 derepression is neuroprotective in a mouse model of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2024;121:e2411303121.
    PubMed    
    
    
    June 2024
20. 
    Correction for Prusiner et al., Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism.
    Proc Natl Acad Sci U S A. 2024;121:e2408899121.
    PubMed    
    
    
    May 2024
21. CAI W, Young CB, Yuan R, Lee B, et al
    Subthalamic nucleus-language network connectivity predicts dopaminergic modulation of speech function in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2024;121:e2316149121.
    PubMed     Abstract available
    
    
    April 2024
22. MOHD RAFIQ N, Fujise K, Rosenfeld MS, Xu P, et al
    Parkinsonism Sac domain mutation in Synaptojanin-1 affects ciliary properties in iPSC-derived dopaminergic neurons.
    Proc Natl Acad Sci U S A. 2024;121:e2318943121.
    PubMed     Abstract available
    
    
    February 2024
23. RILEY MJ, Mitchell CC, Ernst SE, Taylor EB, et al
    A model for stimulation of enzyme activity by a competitive inhibitor based on the interaction of terazosin and phosphoglycerate kinase 1.
    Proc Natl Acad Sci U S A. 2024;121:e2318956121.
    PubMed     Abstract available
    
    
    
24. RONTGEN A, Toprakcioglu Z, Tomkins JE, Vendruscolo M, et al
    Modulation of alpha-synuclein in vitro aggregation kinetics by its alternative splice isoforms.
    Proc Natl Acad Sci U S A. 2024;121:e2313465121.
    PubMed     Abstract available
    
    
    January 2024
25. GILBOA T, Swank Z, Thakur R, Gould RA, et al
    Toward the quantification of alpha-synuclein aggregates with digital seed amplification assays.
    Proc Natl Acad Sci U S A. 2024;121:e2312031121.
    PubMed     Abstract available
    
    
    
26. AUBREY LD, Ninkina N, Ulamec SM, Abramycheva NY, et al
    Substitution of Met-38 to Ile in gamma-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid.
    Proc Natl Acad Sci U S A. 2024;121:e2309700120.
    PubMed     Abstract available
    
    
    
27. TONG Y, Zhang P, Yang X, Liu X, et al
    Decreasing the intrinsically disordered protein alpha-synuclein levels by targeting its structured mRNA with a ribonuclease-targeting chimera.
    Proc Natl Acad Sci U S A. 2024;121:e2306682120.
    PubMed     Abstract available
    
    
    
28. KAKUDA K, Ikenaka K, Kuma A, Doi J, et al
    Lysophagy protects against propagation of alpha-synuclein aggregation through ruptured lysosomal vesicles.
    Proc Natl Acad Sci U S A. 2024;121:e2312306120.
    PubMed     Abstract available
    
    
    December 2023
29. QI C, Verheijen BM, Kokubo Y, Shi Y, et al
    Tau filaments from amyotrophic lateral sclerosis/parkinsonism-dementia complex adopt the CTE fold.
    Proc Natl Acad Sci U S A. 2023;120:e2306767120.
    PubMed     Abstract available
    
    
    November 2023
30. BODILY TA, Ramanathan A, Wei S, Karkisaval A, et al
    In pursuit of degenerative brain disease diagnosis: Dementia biomarkers detected by DNA aptamer-attached portable graphene biosensor.
    Proc Natl Acad Sci U S A. 2023;120:e2311565120.
    PubMed     Abstract available
    
    
    October 2023
31. YESHAW WM, Adhikari A, Chiang CY, Dhekne HS, et al
    Localization of PPM1H phosphatase tunes Parkinson's disease-linked LRRK2 kinase-mediated Rab GTPase phosphorylation and ciliogenesis.
    Proc Natl Acad Sci U S A. 2023;120:e2315171120.
    PubMed     Abstract available
    
    
    
32. LAI Y, Zhao C, Tian Z, Wang C, et al
    Neutral lysophosphatidylcholine mediates alpha-synuclein-induced synaptic vesicle clustering.
    Proc Natl Acad Sci U S A. 2023;120:e2310174120.
    PubMed     Abstract available
    
    
    
33. WANG X, Espadas J, Wu Y, Cai S, et al
    Membrane remodeling properties of the Parkinson's disease protein LRRK2.
    Proc Natl Acad Sci U S A. 2023;120:e2309698120.
    PubMed     Abstract available
    
    
    September 2023
34. KIM DY, Shin JY, Lee JE, Kim HN, et al
    A selective ER-phagy exerts neuroprotective effects via modulation of alpha-synuclein clearance in parkinsonian models.
    Proc Natl Acad Sci U S A. 2023;120:e2221929120.
    PubMed     Abstract available
    
    
    
35. LE GUEN Y, Luo G, Ambati A, Damotte V, et al
    Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes.
    Proc Natl Acad Sci U S A. 2023;120:e2302720120.
    PubMed     Abstract available
    
    
    August 2023
36. YADAVALLI N, Ferguson SM
    LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition.
    Proc Natl Acad Sci U S A. 2023;120:e2303789120.
    PubMed     Abstract available
    
    
    July 2023
37. ZHANG S, Yi S, Wang L, Li S, et al
    Cyclin-G-associated kinase GAK/dAux regulates autophagy initiation via ULK1/Atg1 in glia.
    Proc Natl Acad Sci U S A. 2023;120:e2301002120.
    PubMed     Abstract available
    
    
    June 2023
38. MATSUI H, Ito S, Matsui H, Ito J, et al
    Phosphorylation of alpha-synuclein at T64 results in distinct oligomers and exerts toxicity in models of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2023;120:e2214652120.
    PubMed     Abstract available
    
    
    April 2023
39. PENG JY, Qi ZX, Yan Q, Fan XJ, et al
    Ameliorating parkinsonian motor dysfunction by targeting histamine receptors in entopeduncular nucleus-thalamus circuitry.
    Proc Natl Acad Sci U S A. 2023;120:e2216247120.
    PubMed     Abstract available
    
    
    
40. SCHWARZ TC, Beier A, Ledolter K, Gossenreiter T, et al
    High-resolution structural information of membrane-bound alpha-synuclein provides insight into the MoA of the anti-Parkinson drug UCB0599.
    Proc Natl Acad Sci U S A. 2023;120:e2201910120.
    PubMed     Abstract available
    
    
    March 2023
41. CHEUNG THC, Ding Y, Zhuang X, Kang UJ, et al
    Learning critically drives parkinsonian motor deficits through imbalanced striatal pathway recruitment.
    Proc Natl Acad Sci U S A. 2023;120:e2213093120.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.